Your account has not been permission, data will display ***. Please Upgrade to use. Close notice
Hướng dẫn sử dụng

Mekophar Chemical Pharmaceutical Joint Stock Company (UPCoM: MKP)

30,000

(%)
04/25/2024 15:19

Open30,000

High30,000

Low30,000

Vol3,200

Market Cap.758.05

Remain Bid13,600

Remain Ask4,100

52Wk High30,000

52Wk Low23,600

52Wk Avg Vol2,508

Foreign Buy-

Frgn Owned(%)15.58

Dividend1,000

Dividend Yield0.03

Beta1.02

EPS1,397

P/E21.47

F P/E7.66

BVPS50,463

P/B0.59

Financial ratios of latest trading date, EPS in the company's latest quarter Financial Statement
View with MKP: OPC HSV AAA NDP DVN
Trending: HPG (93,407) - NVL (81,568) - DIG (76,502) - VND (69,099) - MBB (66,883)
1 day | 5 day | 3 months | 6 months | 12 months
- Mekophar Chemical Pharmaceutical Joint Stock Company (MKP), formerly known as Central Chemical Pharmaceutical 24, was established in 2001, is one of the first companies in Vietnam to reach GMP - WHO. The firm is producing over 300 chemical products in five major groups: powder anti-body, fruit transmitting, beta-lactam, non-beta-lacam, liquid and ointment chemicals. The company products are delivered and consumed a... View more
DateCloseChangeVolume
04/25/202430,0000 (0.00%)3,200
04/24/202430,0002,000 (+7.14%)3,300
04/23/202428,000-900 (-3.11%)1,802
04/22/202428,000400 (+1.45%)4,313
04/19/202427,600-2,400 (-8%)300
Volume: share, Price: Dong
Unit: Million Dong
Unit: Million Dong
05/30/2023MKP Dividend payment in cash with 10.00% for 2022 (Record date)
05/30/2023MKP Dividend payment in cash with 10.00% for 2022
05/30/2022MKP Dividend payment in cash with 8.00% for 2021
05/30/2022MKP Dividend payment in cash with 8.00% for 2021 (Record date)
06/14/2021MKP Dividend payment in cash with 10.00% for 2020
04/19/2024Consolidated FS Quarter 1 of 2024
04/19/2024Parent Company FS Quarter 1 of 2024
04/19/2024Annual report 2023
04/16/2024Explanation for Audited Parent Company FS 2023
04/02/2024Audited Consolidated FS 2023

Mekophar Chemical Pharmaceutical Joint Stock Company

Name: Mekophar Chemical Pharmaceutical Joint Stock Company

Abbreviation:MEKOPHAR

Address: 297/5 Ly Thuong Kiet, Ward 15 District 11 Ho Chi Minh

Telephone: (84.28) 3865 0258 - 3865 0363 - 3865 0436

Fax: (84.28) 3865 0394

Email:info@mekophar.com.vn

Website:https://mekophar.com

Exchange: UPCoM

Sector: Manufacturing

Industry: Chemical - Pharmaceutical

Listing date: 01/29/2018

Chartered capital: 232,490,000,000

Listed shares: 25,545,867

Shares outstanding: 25,268,221

Status: Operating

Tax code: 0302533156

Establishment license: 1589/QÐ-TTg

Issued date: 12/19/2001

Business license: 0302533156

Issued date: 02/08/2002

Main business scope:

- Producing and trading chemical products, materials, health equipments.

- Producing packages used in chemical industries.

- Producing and trading technology foods.

- Providing services in office leasing, building leasing.

- Renting apartments.

- 1975: Central Chemical Pharmaceutical 24 established in 2001, a member of Vietnam General Chemical Corporation.

- 1985: Central Chemical Pharmaceutical 24 merged with Central Chemical Pharmaceutical 22 into Central Chemical Pharmaceutical 24- MEKOPHAR.

- November 1992, the firm established Mekong Chemical Pharmaceutical Joint stock company.

- July 1993: the firm joint-ventured with Korean Woopyung to establish Woopyung - Mekophar.

- 01 June 2000: Central Chemical Pharmaceutical 24- MEKOPHAR bought Woopyung - Mekophar and made it a anti-body production factory.

- 19 December 2001: Central Chemical Pharmaceutical 24- MEKOPHAR changed the business model into joint stock company and changed name to Mekophar Chemical Pharmaceutical Joint Stock Company with initial charter capital of VND36 billion.

- June 2003: Mekong Chemical Pharmaceutical Joint stock company merged into Mekophar Chemical Pharmaceutical Joint Stock Company.

- 2003: Invested in building An Sinh hospital and the hospital started operation from May 7, 2006.

- March 2006: Increased charter capital to VND54 billion.

- December 2006: Increased charter capital to VND84 billion.

- September 2008: Increased charter capital to VND92.1 billion.

- June 2, 2010: Listed on the HOSE.

- 2011: Increased charter capital to VND101 billion.

- 12 July 2012: Delisted from HOSE.

- 2014: Increased charter capital to VND131 billion.

- 2015: Increased charter capital to VND151 billion.

- 2016: Increased charter capital to VND194 billion.

- January 29, 2018: Traded on UPCOM market.

ItemsUnit
PriceVND
VolumeShares
Foreigner's, Yield%
Mkt CapbVND
Financial indicatorsmVND
EPS, BVPS, DividendVND
P/E, F P/E, P/BTimes
ROS, ROA, ROE%
1. The accounting period for the equitization year is defined as of the company's establishment date.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
* Vietstock tổng hợp thông tin từ các nguồn đáng tin cậy vào thời điểm công bố cho mục đích cung cấp thông tin tham khảo. Vietstock không chịu trách nhiệm đối với bất kỳ kết quả nào từ việc sử dụng các thông tin này.